Bioko Island Malaria Control Project (BIMCP) Phase III
Country: Equatorial Guinea
Funders: The Government of Equatorial Guinea, Marathon Oil, Noble Energy, Sonagas, GEPetrol and Atlantic Methanol (AMPCO)
When Marathon Oil Corporation began operating its oil and gas operations Equatorial Guinea, its workforce and that of the surrounding community on Bioko Island was greatly impacted by malaria illness and deaths. As a result, Marathon Oil came to lead a consortium funding local malaria control efforts through a production-sharing agreement with the Government of Equatorial Guinea, and with participation by other generous donors (AMPCO, Noble Energy, GEPetrol and Sonagas). MCDI has implemented a series of integrated malaria control measures to substantially reduce morbidity and mortality caused by malaria on Bioko Island, Equatorial Guinea since 2003 under the Bioko Island Malaria Control Project (BIMCP). Currently in its third five-year phase (2014-2018), the project’s interventions build on those established during Phase I (2004-2008) and Phase II (2009-2013) and are centered on indoor residual spraying, the distribution of long-lasting insecticidal nets, intermittent preventive therapy for pregnant women, malaria case management, epidemiological surveillance, vector monitoring, advocacy, informative, education and communication (IEC) and behavior change communication (BCC), and other focal activities stratified according to geographic areas of higher or persistent transmission. In the past, the BIMCP has also served as a proving ground for novel approaches such as mass screen and treat (MSAT), focal screen and treat (FSAT), larval source management, and environmental management. In coordination with the national malaria control program, the project has made a strong commitment to investing in human resource development, capacity building and horizontal integration, so as to prepare the Ministry of Health and Social Welfare to assume responsibility for sustaining the malaria control activities. The BIMCP is implemented with technical assistance from the London School of Hygiene and Tropical Medicine (LSHTM) on serological analysis and the design of an annual Malaria Indicator Survey, the Liverpool School of Tropical Medicine (LSTM) for metabolic resistance to insecticides and a disease data management system, and Texas A&M University as a partner in molecular-level analysis of mosquito samples collected on the island. Operational research has been conducted in a variety of technical areas, with regular publication of results.
Key Achievements as of 2016: